Venture capitals in venture ecosystem in Japan

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Bio-ventures are indispensable for the progress of life science and medical care and the prosperity of the pharmaceutical industry. It is also important to form an ecosystem surrounding ventures. DDS Venture capitals(VC)encourage venture start-ups, invest risk money in ventures in uncertain business stages, and support discontinuous business growth. There are various negative situations in the venture ecosystem in Japan, but each player is working with the will of indomitable in anticipation of its growth.The origin of drug discovery research in academia is the desire to cure the patient in front of us, and there is a strong unmet medical need. As a VC, we would like to pay attention to the movement of social implementation of academia technology and face negative situations in the venture ecosystem in Japan.

Cite

CITATION STYLE

APA

Hasegawa, H. (2022). Venture capitals in venture ecosystem in Japan. Drug Delivery System, 37(1), 54–62. https://doi.org/10.2745/dds.37.54

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free